The Memorial Sloan Kettering Cancer Center (MSK) is a leading global entity in cancer research and treatment, housing over 100 labs and nine innovative programs. MSK focuses on comprehensive and in-depth research into the complex nature of cancer, exploring gene and cell biology and developing revolutionary immune-based treatments. MSK’s Human Oncology & Pathogenesis Program (HOPP) speeds up the transition from lab findings to clinical application, encouraging collaborative efforts between researchers and clinicians. Education is a priority for MSK, offering several programs for aspiring clinicians and scientists. MSK cares for patients worldwide, providing resources for patients and caregivers, and offers easy electronic access to medical information through MyMSK. They accept contributions to fund continued research, underlining their commitment to defeating cancer.
Full article here: https://medium.com/@lawsuithelpdesk/innovative-cancer-conquests-a-deep-dive-into-memorial-sloan-ketterings-groundbreaking-research-b474672db5a4